# A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery

> **NCT05079061** · PHASE4 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 1300 (estimated)

## Conditions studied

- Primary Postpartum Hemorrhage
- Misoprostol
- Delivery Complication

## Interventions

- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT05079061
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079061, "A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05079061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*